Cardiometabolic Syndrome Part 2: Pharmacological Management, Public Health Strategies, and Future Direction
Authors:
- Soo LimSLSoo Lim
- You-Cheol HwangYHYou-Cheol Hwang
- Jang Won SonJSJang Won Son
- Seung-Hwan LeeSLSeung-Hwan Lee
- Chang Hee JungCJChang Hee Jung
- Hyun-Jin KimHKHyun-Jin Kim
- Hyunjung LimHLHyunjung Lim
- Seong-Mi ParkSPSeong-Mi Park
- Jang-Young KimJKJang-Young Kim
- Jong Chan YounJYJong Chan Youn
- Sung Kee RyuSRSung Kee Ryu
- Sihoon LeeSLSihoon Lee
Open Access
- 1 January 2026
- journal article
- Published by XMLink in CardioMetabolic Syndrome Journal
- Vol. 6 (2) , 193
Abstract
Lim S, et al. Cardiometab Syndr J. 2026 ;6:e26. https://doi.org/10.51789/cmsj.2026.6.e26Keywords
This publication has 107 references indexed in Scilit:
- Rationale, Design, and Baseline Clinical Characteristics of the Ziltivekimab Cardiovascular Outcomes TrialJAMA Cardiology, 2026
- Fibrates : Do They Still Have a Role in Therapy in 2025?Current Atherosclerosis Reports, 2025
- Bridging Prevention and Imaging: The Influence of Statins on CAC and CCTA FindingsCurrent Atherosclerosis Reports, 2025
- RNA Interference With Zilebesiran for Mild to Moderate HypertensionJAMA, 2024
- Incretin hormones and type 2 diabetesDiabetologia, 2023
- Effect of Omega-3 Polyunsaturated Fatty Acids on Cardiovascular Outcomes in Patients with Diabetes: A Meta-analysis of Randomized Controlled TrialsAdvances in Nutrition, 2023
- The Potential Cardiometabolic Effects of Long-Chain ω-3 Polyunsaturated Fatty Acids: Recent Updates and ControversiesAdvances in Nutrition, 2023
- Effect of Subcutaneous Tirzepatide vs Placebo Added to Titrated Insulin Glargine on Glycemic Control in Patients With Type 2 DiabetesJAMA, 2022
- Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascular RiskJAMA, 2020
- Physiology and role of PCSK9 in vascular disease: Potential impact of localized PCSK9 in vascular wallJournal of Cellular Physiology, 2020